National HealthCare CEO sells 1,500 shares at $237

NATIONAL HEALTHCARE CORP (NHC) reported that CEO and director Stephen Fowler Flatt sold 1,500 shares of Common Stock on 2026-08-19 at $237.08 per share in an open-market or private sale, leaving him with 65,487 directly held shares.

Rhea-AI Filing Summary

NATIONAL HEALTHCARE CORP (NHC) reported that CEO and director Stephen Fowler Flatt sold 1,500 shares of Common Stock on 2026-08-19 at $237.08 per share in an open-market or private sale, leaving him with 65,487 directly held shares. He also continues to hold several option awards on NHC Common Stock with varying exercise prices and expirations.

Insider Trade Summary

Net Seller: 1,500 shares

Net Sell 5 txns

Insider Flatt Stephen Fowler

Role CEO

Sold 1,500 shs ($356K)

Type	Security	Shares	Price	Value
Sale	Common Stock	1,500	$237.08	$356K
holding	Option to Purchase Common Stock	--	--	--
holding	Option to Purchase Common Stock	--	--	--
holding	Option to Purchase Common Stock	--	--	--
holding	Option to Purchase Common Stock	--	--	--

Holdings After Transaction: Common Stock — 65,487 shares (Direct); Option to Purchase Common Stock — 41,294 contracts (Direct)

Key Figures

Shares sold: 1,500 shares of Common Stock Sale price per share: $237.08 per share Shares held after transaction: 65,487 shares +5 more

8 metrics

Shares sold 1,500 shares of Common Stock Sale on 2026-08-19 by CEO Stephen Fowler Flatt

Sale price per share $237.08 per share Price for the 1,500-share sale on 2026-08-19

Shares held after transaction 65,487 shares Direct Common Stock holdings following the sale

Option exercise price $53.94 Option to purchase 4,294 underlying shares, expiring 2028-03-08

Option exercise price $94.10 Option to purchase 5,000 underlying shares, expiring 2029-03-05

Option exercise price $90.62 Option to purchase 12,000 underlying shares, expiring 2030-02-28

Option exercise price $157.13 Option to purchase 20,000 underlying shares, expiring 2031-02-23

Net shares bought/sold -1,500 shares Net-sell direction in transaction summary

Key Terms

open market or private transaction, Option to Purchase Common Stock, exercise price, expiration date

4 terms

open market or private transaction market

"transaction_code_description": "Sale in open market or private transaction"

Option to Purchase Common Stock financial

"security_title": "Option to Purchase Common Stock"

exercise price financial

"conversion_or_exercise_price": "53.9400"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date": "2028-03-08"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did NHC report for CEO Stephen Fowler Flatt?

NATIONAL HEALTHCARE CORP reported that CEO Stephen Fowler Flatt sold 1,500 shares of NHC Common Stock on 2026-08-19 at $237.08 per share in a sale categorized as an open market or private transaction.

How many NHC shares does the CEO hold after the reported sale?

After the reported sale, CEO Stephen Fowler Flatt directly holds 65,487 shares of NATIONAL HEALTHCARE CORP Common Stock, as stated in the Form 4 filing.

At what price were the NHC shares sold in this Form 4 filing?

The 1,500 shares of NATIONAL HEALTHCARE CORP (NHC) Common Stock were sold at a price of $237.08 per share, according to the Form 4 data.

What option awards on NHC stock does the CEO hold according to this filing?

Stephen Fowler Flatt holds options to purchase NHC Common Stock including 4,294 shares at $53.94, 5,000 shares at $94.10, 12,000 shares at $90.62, and 20,000 shares at $157.13, each with specified future expiration dates.

Were any stock options exercised in the NHC Form 4 transaction summary?

No. The transaction summary shows an exerciseCount of 0 and exerciseShares of 0, indicating no option exercises were reported in this Form 4 for NATIONAL HEALTHCARE CORP.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/20/2026 - 04:18 PM Accepted by SEC EDGAR 08/20/2026 - 04:17 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Flatt Stephen Fowler

(Last) (First) (Middle)

100 VINE STREET

(Street)

MURFREESBORO TENNESSEE 37130

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTHCARE CORP [ NHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/19/2026		S		1,500	D	$237.08	65,487	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Common Stock	$53.94							03/08/2024	03/08/2028	Common Stock	4,294		4,294	D
Option to Purchase Common Stock	$94.1							03/05/2025	03/05/2029	Common Stock	5,000		5,000	D
Option to Purchase Common Stock	$90.62							02/28/2026	02/28/2030	Common Stock	12,000		12,000	D
Option to Purchase Common Stock	$157.13							02/23/2027	02/23/2031	Common Stock	20,000		20,000	D

Explanation of Responses:

	/s/ Stephen Flatt	08/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)